Holbrook Kerr, SVP and Chief Commercial Officer at Avanos Medical Inc. ($AVNS), sold shares on the open market four times in the last year, totaling about $165,000. His most recent sale occurred on November 18, 2025. These sales rank 8,817th among 11,678 individual insiders, where the average is $8.6 million across about 6.4 transactions. Kerr made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 18, 2025 | AVANOS MEDICAL, INC. | $AVNS | Holbrook Kerr | SVP, Chief Commercial Officer | S | Common Stock | 100 | $11.01 | 84,926.0000 | 46,416,998 | 0.12% | 0.00% |
| Nov. 18, 2025 | AVANOS MEDICAL, INC. | $AVNS | Holbrook Kerr | SVP, Chief Commercial Officer | S | Common Stock | 13834 | $11.00 | 85,026.0000 | 46,416,998 | 13.99% | 0.03% |
| Nov. 18, 2025 | AVANOS MEDICAL, INC. | $AVNS | Holbrook Kerr | SVP, Chief Commercial Officer | S | Common Stock | 305 | $11.02 | 83,860.0000 | 46,416,998 | 0.36% | 0.00% |
| Nov. 18, 2025 | AVANOS MEDICAL, INC. | $AVNS | Holbrook Kerr | SVP, Chief Commercial Officer | S | Common Stock | 761 | $11.01 | 84,165.0000 | 46,416,998 | 0.90% | 0.00% |
| March 7, 2025 | AVANOS MEDICAL, INC. | $AVNS | Holbrook Kerr | SVP, Chief Commercial Officer | A | Common Stock | 22877 | $0.00 | 98,860.0000 | 45,963,000 | 30.11% | 0.05% |
| March 7, 2025 | AVANOS MEDICAL, INC. | $AVNS | Holbrook Kerr | SVP, Chief Commercial Officer | A | Employee Stock Option (right to buy) | 49088 | $0.00 | 49,088.0000 | 45,963,000 | 9999.99% | 0.11% |
| March 6, 2025 | AVANOS MEDICAL, INC. | $AVNS | Holbrook Kerr | SVP, Chief Commercial Officer | F | Common Stock | 2474 | $15.30 | 79,573.0000 | 45,963,000 | 3.02% | 0.01% |
| March 6, 2025 | AVANOS MEDICAL, INC. | $AVNS | Holbrook Kerr | SVP, Chief Commercial Officer | F | Common Stock | 3590 | $15.30 | 75,983.0000 | 45,963,000 | 4.51% | 0.01% |
| March 6, 2025 | AVANOS MEDICAL, INC. | $AVNS | Holbrook Kerr | SVP, Chief Commercial Officer | S | Common Stock | 7000 | $15.25 | 82,047.0000 | 45,963,000 | 7.86% | 0.02% |
| March 4, 2025 | AVANOS MEDICAL, INC. | $AVNS | Holbrook Kerr | SVP, Chief Commercial Officer | F | Common Stock | 1803 | $15.13 | 90,590.0000 | 45,963,000 | 1.95% | 0.00% |
| March 4, 2025 | AVANOS MEDICAL, INC. | $AVNS | Holbrook Kerr | SVP, Chief Commercial Officer | F | Common Stock | 1543 | $15.13 | 89,047.0000 | 45,963,000 | 1.70% | 0.00% |
| March 4, 2025 | AVANOS MEDICAL, INC. | $AVNS | Holbrook Kerr | SVP, Chief Commercial Officer | M | Common Stock | 5145 | $0.00 | 92,393.0000 | 45,963,000 | 5.90% | 0.01% |
| March 18, 2024 | AVANOS MEDICAL, INC. | $AVNS | Holbrook Kerr | SVP, Chief Commercial Officer | M | Common Stock | 2531 | $0.00 | 89,727.0000 | 46,174,337 | 2.90% | 0.01% |
| March 18, 2024 | AVANOS MEDICAL, INC. | $AVNS | Holbrook Kerr | SVP, Chief Commercial Officer | F | Common Stock | 2840 | $19.09 | 86,131.0000 | 46,174,337 | 3.19% | 0.01% |
| March 18, 2024 | AVANOS MEDICAL, INC. | $AVNS | Holbrook Kerr | SVP, Chief Commercial Officer | F | Common Stock | 756 | $19.09 | 88,971.0000 | 46,174,337 | 0.84% | 0.00% |
| March 6, 2024 | AVANOS MEDICAL, INC. | $AVNS | Holbrook Kerr | SVP, Chief Commercial Officer | F | Common Stock | 2618 | $19.00 | 87,196.0000 | 46,174,337 | 2.91% | 0.01% |
| March 6, 2024 | AVANOS MEDICAL, INC. | $AVNS | Holbrook Kerr | SVP, Chief Commercial Officer | A | Common Stock | 36573 | $19.14 | 89,814.0000 | 46,174,337 | 68.69% | 0.08% |
| March 5, 2024 | AVANOS MEDICAL, INC. | $AVNS | Holbrook Kerr | SVP, Chief Commercial Officer | F | Common Stock | 1502 | $18.76 | 52,310.0000 | 46,174,337 | 2.79% | 0.00% |